Renal function in amyotrophic lateral sclerosis patients on long-term treatment with edaravone

Edaravone, a free radical-scavenger, was approved in Japan for the treatment of amyotrophic lateral sclerosis (ALS). However, the effect of the drug on renal function in ALS patients remains unclear. This study aimed to investigate renal function in ALS patients on long-term treatment with edaravone...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakimoto, Asako, Ishizaki, Masatoshi, Ueyama, Hidetsugu, Maeda, Yasushi, Ueda, Mitsuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154461/
https://www.ncbi.nlm.nih.gov/pubmed/34032759
http://dx.doi.org/10.1097/MD.0000000000026127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154461/
https://www.ncbi.nlm.nih.gov/pubmed/34032759
http://dx.doi.org/10.1097/MD.0000000000026127

Ejemplares similares